WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ENZIPVIC was filed as Word mark on 01/11/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1535760 |
| Countries | 
|
| Base trademark |
No. 88514725,
July 15, 2019
|
| Application date | January 11, 2020 |
| Expiration date | January 11, 2030 |
Trademark owner
88 Sidney Street
Cambridge MA 02139-4169
US
Cambridge MA 02139-4169
US
Trademark representatives
Tepper & Eyster, PLLC,
3724 Benson Drive
US
goods and services
05
Pharmaceutical products for the prevention and treatment of
blood disorders; pharmaceutical products for the prevention
and treatment of sickle cell disease, PKD and beta
thalassemia; pharmaceutical products for the prevention and
treatment of rare genetic diseases effecting red blood
cells; pharmaceutical products for the prevention and
treatment of various anemias
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 18, 2023 | 2023/4 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 17, 2021 | 2021/39 Gaz | CA | Rejection |
| July 1, 2021 | 2021/26 Gaz | JP | Rejection |
| February 5, 2021 | 2021/6 Gaz | GB | Rejection |
| October 29, 2020 | 2020/44 Gaz | EM | Rejection |
| January 11, 2020 | 2020/22 Gaz | US | Registration |
ID: 141535760